Your browser doesn't support javascript.
loading
Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients.
Tao, T; Ma, X; Yang, J; Zou, J-Y; Ji, S-M; Tan, Y-S; Gong, W; Du, F; Xu, J; Ye, C-M; Tang, X-W; Wu, D-P; Xue, S-L.
Afiliación
  • Tao T; Department of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ma X; 1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovati
  • Yang J; Department of Clinical Nutrition, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zou JY; Suzhou Health College, Suzhou, China.
  • Ji SM; 1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovati
  • Tan YS; Department of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Gong W; Department of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Du F; Department of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xu J; Department of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ye CM; Department of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Tang XW; 1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovati
  • Wu DP; 1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovati
  • Xue SL; 1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovati
Blood Cancer J ; 5: e308, 2015 Apr 17.
Article en En | MEDLINE | ID: mdl-25885428
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Anticuerpos Monoclonales Humanizados / Enfermedad Injerto contra Huésped / Anticuerpos Monoclonales Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Anticuerpos Monoclonales Humanizados / Enfermedad Injerto contra Huésped / Anticuerpos Monoclonales Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: China